NOW ENROLLING

Phase III trial in relapsed/refractory acute myeloid leukemia (AML)

Patients with relapsed/refractory AML

Learn about this Phase III AML trial

MIRROS
BioOncology Genentech

© 2019 Genentech USA, Inc. All rights reserved. BIO/040218/0052(2)